These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2284620)

  • 1. Clinical examination of heparin-Ca in myocardial infarction patients.
    Páder K; Kerkovits G
    Ther Hung; 1990; 38(3):114-6. PubMed ID: 2284620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of two treatment durations (6 days and 14 days) of a low molecular weight heparin with a 6-day treatment of unfractionated heparin in the initial management of unstable angina or non-Q wave myocardial infarction: FRAX.I.S. (FRAxiparine in Ischaemic Syndrome).
    Eur Heart J; 1999 Nov; 20(21):1553-62. PubMed ID: 10529323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are activated clotting times helpful in the management of anticoagulation with subcutaneous low-molecular-weight heparin?
    Henry TD; Satran D; Knox LL; Iacarella CL; Laxson DD; Antman EM
    Am Heart J; 2001 Oct; 142(4):590-3. PubMed ID: 11579347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clopidogrel-rt-PA-heparin combination in the treatment of acute myocardial infarction.
    Bassand JP; Cariou R; Grollier G; Kragten J; Wolf JE; Heyndrickx GR
    Semin Thromb Hemost; 1999; 25 Suppl 2():69-75. PubMed ID: 10440428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low molecular weight heparin for treatment of acute myocardial infarction (FAMI): Fragmin (dalteparin sodium) in acute myocardial infarction.
    Kakkar VV; Iyengar SS; De Lorenzo F; Hargreaves JR; Kadziola ZA;
    Indian Heart J; 2000; 52(5):533-9. PubMed ID: 11256775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis).
    Peters RJ; Spickler W; Théroux P; White H; Gibson M; Molhoek PG; Anderson HV; Weitz JI; Hirsh J; Weaver WD
    Am Heart J; 2001 Aug; 142(2):237-43. PubMed ID: 11479461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of minidoses of heparin on the blood coagulation and thrombocytic links of hemostasis in myocardial infarct in middle-aged and elderly patients].
    Nechaev DD; Bochko II; Kuz'mina LF; Martynov IV; Khloponina NN
    Ter Arkh; 1987; 59(10):105-8. PubMed ID: 3433205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Heparin].
    Aiach M; Fiessinger JN; Chousterman M
    Rev Prat; 1977 Dec; 27(57):3953-74. PubMed ID: 345399
    [No Abstract]   [Full Text] [Related]  

  • 9. [Subcutaneous heparin-calcium therapy: clinical and laboratory experience].
    Boda Z; Rák K
    Orv Hetil; 1989 Oct; 130(44):2347-9. PubMed ID: 2812763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin and warfarin therapy after acute myocardial infarction.
    Yedinak KC; Sproat TT
    Clin Pharm; 1993 Mar; 12(3):197-215. PubMed ID: 8491077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Full dose subcutaneous heparin therapy.
    Hollander G; Rothenberg R; Greengart A; Shani J; Lichstein E
    N Y State J Med; 1989 Jul; 89(7):387-9. PubMed ID: 2761866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly variable anticoagulant response after subcutaneous administration of high-dose (12,500 IU) heparin in patients with myocardial infarction and healthy volunteers.
    Kroon C; ten Hove WR; de Boer A; Kroon JM; van der Pol JM; Harthoorn-Lasthuizen EJ; Schoemaker HC; van der Meer FJ; Cohen AF
    Circulation; 1992 Nov; 86(5):1370-5. PubMed ID: 1423948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prolonged anticoagulant treatment by subcutaneous injections of calcium heparinate].
    Demange J; Renais J; Scebat L; Lenegre J
    Presse Med (1893); 1967 Jun; 75(29):1499-502. PubMed ID: 6026886
    [No Abstract]   [Full Text] [Related]  

  • 14. Randomized comparison of enoxaparin with unfractionated heparin following fibrinolytic therapy for acute myocardial infarction.
    Baird SH; Menown IB; Mcbride SJ; Trouton TG; Wilson C
    Eur Heart J; 2002 Apr; 23(8):627-32. PubMed ID: 11969277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Megadose heparin and streptokinase produce similar TIMI 3 flow at discharge in patients of acute myocardial infarction presenting between 7-12 hours.
    Dwivedi SK; Pramod K; Gupta R; Saran RK; Narain VS; Puri VK
    Indian Heart J; 2000; 52(2):183-6. PubMed ID: 10893895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized factorial trial of high-dose intravenous streptokinase, of oral aspirin and of intravenous heparin in acute myocardial infarction. ISIS (International Studies of Infarct Survival) pilot study.
    Eur Heart J; 1987 Jun; 8(6):634-42. PubMed ID: 2887430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacy of once daily parnaparin and unfractionated heparin in unstable angina pectoris: PRIME CARE study.
    PRIME CARE Study Investigators Group
    Indian Heart J; 2005; 57(6):648-54. PubMed ID: 16521631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The feasibility and tolerability of prolonged treatment with low doses of heparin-calcium administered subcutaneously in infarct patients. A multicenter clinical study].
    Fernandez C; Proto C; Schiassi M; Scotti A
    Recenti Prog Med; 1993 Dec; 84(12):834-42. PubMed ID: 8108597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a standardized heparin nomogram to achieve therapeutic anticoagulation after thrombolytic therapy in myocardial infarction. TIMI 4 investigators. Thrombolysis in Myocardial Infarction.
    Flaker GC; Bartolozzi J; Davis V; McCabe C; Cannon CP
    Arch Intern Med; 1994 Jul; 154(13):1492-6. PubMed ID: 8018004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of low-molecular-weight heparin and unfractionated heparin in the treatment of unstable angina].
    Godoy I; Herrera C; Zapata C; Kunstmann S; Abufhele A; Corbalán R
    Rev Med Chil; 1998 Mar; 126(3):259-64. PubMed ID: 9674294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.